Asialoglycoprotein receptors are highly abundant on the hepatocyte surface and have specific binding sites for blood serum glycoproteins. Such discovery resulted in development of liver-targeted drug delivery systems because modification of the liposomal surface by carbohydrate derivatives results in an increase of endocytosis, which facilitates selective uptake of such systems by hepatocytes. In this study we have synthesized novel lactose derivatives containing a palmitic hydrophobic domain. They were used for modification of the liposome surface. Transfection activity of modified liposomes was analyzed on the HepG2 cell line (hepatocytes) and showed an increase in the transfection efficiency as compared to the non-modified liposomes. At the same time transfection activities of modified and non-modified liposomes were similar in the case of a non-hepatocyte cell line (293T). The novel lactose-based glycoconjugates may be a promising tool for developing efficient vectors for delivery of nucleic acids to hepatocytes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.18097/PBMC20176305467 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of Non-Modified as Well as Surface-Modified SiO Nanoparticles on Red Blood Cells, Biological and Model Membranes.
Int J Mol Sci
July 2023
Department of Physics and Biophysics, Wrocław University of Environmental and Life Sciences, Norwida St. 25, 50-375 Wrocław, Poland.
Article Synopsis
- Nanoparticles, particularly silica nanoparticles, are valuable in medicine, especially for cancer treatment due to their unique properties.
- The study focused on assessing the cytotoxic effects of three types of silica nanoparticles (SiO2, SiO2-SH, and SiO2-COOH) on red blood cells and their impact on biological membranes.
- The findings revealed that nanoparticle toxicity is concentration-dependent, with SiO2-COOH notably altering red blood cell shape and membrane fluidity, highlighting potential applications in biomedicine.
Original and liposome-modified indocyanine green-assisted fluorescence study with animal models.
Lasers Med Sci
June 2023
Division of Electrical and Computer Engineering, College of Engineering, Louisiana State University, LA70803, Baton Rouge, USA.
Article Synopsis
- Medical diagnosis utilizes bio-imaging techniques, particularly ICG-based sensors for fluorescence imaging, to detect diseases.
- The study focused on enhancing fluorescence signals by using liposome-modified ICG (MLM-ICG), which had an optimal size of 100-300 nm, leading to the highest fluorescence intensity compared to other samples tested.
- Results indicate that MLM-ICG is a safer and more efficient optical agent than non-modified ICG, with the potential for improved biosensors for diagnosing diseases.
Improved targeting delivery of WED-load immunoliposomes modified with SP-A mAb for the treatment of pulmonary fibrosis.
Colloids Surf B Biointerfaces
April 2023
State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. Electronic address:
The epithelial-mesenchymal transition (EMT) of type Ⅱ alveolar epithelial cells (AECS Ⅱ) induced by transforming growth factor (TGF-β1) is a primary pathogenesis of pulmonary fibrosis (PF). To augment the therapeutic potency of wedelolactone (WED) for PF, herein, pulmonary surfactant protein A (SP-A) specifically expressed on AECS Ⅱ was selected as the targeted receptor. Immunoliposomes modified with SP-A monoclonal antibody (SP-A mAb), novel anti-PF drug delivery systems, were developed and investigated in vivo and in vitro.
View Article and Find Full Text PDFMannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages.
Drug Deliv Transl Res
July 2023
Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Campus Vida, Universidade de Santiago de Compostela, Santiago de Compostela, 15782, Spain.
Tumor-associated macrophages (TAMs), a class of immune cells that play a key role in tumor immunosuppression, are recognized as important targets to improve cancer prognosis and treatment. Consequently, the engineering of drug delivery nanocarriers that can reach TAMs has acquired special relevance. This work describes the development and biological evaluation of a panel of hyaluronic acid (HA) nanocapsules (NCs), with different compositions and prepared by different techniques, designed to target macrophages.
View Article and Find Full Text PDFFructose and biotin co-modified liposomes for dual-targeting breast cancer.
J Liposome Res
June 2022
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, China.
Chemotherapy, as the main treatment for breast cancer, inevitably damages normal tissues due to the lack of targeting. Various nano targeting drug delivery systems (TDDS) have the potential to be developed as anticancer therapeutics. Although mono-ligand-directed liposomes have been used with some success, dual-ligand-directed liposomes exhibit promising advantages.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!